Exacerbation of ulcerative colitis after rituximab salvage therapy

Inflammatory Bowel Diseases

Volumn 13, Issue 11, 2007, Pages 1365-1368

  Goetz, Martin ^a   Atreya, Raja ^a   Ghalibafian, Maryam ^a   Galle, Peter R ^a   Neurath, Markus F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

CD20; Inflammatory bowel disease; Interleukin 10; Rituximab; Therapy; Ulcerative colitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; B LYMPHOCYTE ANTIBODY; CD20 ANTIBODY; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; INTERLEUKIN 10; MESALAZINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; VALGANCICLOVIR;

ABDOMINAL RADIOGRAPHY; ABSENCE OF SIDE EFFECTS; ADULT; ANAMNESIS; ARTHROPATHY; ARTICLE; B LYMPHOCYTE; CASE REPORT; CLINICAL FEATURE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG MEGADOSE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LEUKAPHERESIS; LUNG ALVEOLITIS; MALE; PANCREATITIS; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCTOCOLECTOMY; SALVAGE THERAPY; SIGMOIDOSCOPY; TREATMENT OUTCOME; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; COLITIS, ULCERATIVE; HUMANS; INTERLEUKIN-10; MIDDLE AGED; SALVAGE THERAPY;

EID: 36749004359     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20215     Document Type: Article

References (15)

1. Neurath MF, Finotto S, Glimcher LH. The role of Th1/Th2 polarization in mucosal immunity. Nat Med. 2002;8:567-573.
2. Edwards JC, Cambridge G. Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology. 2001;40:205-211.
3. Edwards JC, Szczepanski L, Szechinski J, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004;350:2572-2581.
4. Atreya R, Mudter J, Finotto S, et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med. 2000;6:583-588.
5. Targan, SR, Hanauer, SB, van Deventer, SJ, et al. A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. N Engl J Med. 1997;337:1029.
6. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462-2476.
7. Wirtz S, Neurath MF. Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int J Colorectal Dis. 2000;15:144-160.
8. Brandtzaeg P, Johansen FE. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev. 2005;206:32-63.
9. Olson TS, Bamias G, Naganuma M, et al. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J Clin Invest. 2004;114:389-398.
10. Macpherson A, Khoo UY, Forgacs I, et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut. 1996;38:365-375.
11. Mizoguchi E, Mizoguchi A, Preffer FI, et al. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol. 2000;12:597-605.
12. Mizoguchi A, Mizoguchi E, Smith RN, et al. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med. 1997;186:1749-1756.
13. Mizoguchi E, Mizoguchi A, Preffer FI, et al. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol. 2000;12:597-605.
14. Dalwadi H, Wei B, Schrage M, et al. B cell developmental requirement for the G alpha i2 gene. J Immunol. 2003;170:1707-1715.
15. Wei B, Velazquez P, Turovskaya O, et al. Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci U S A. 2005;102:2010-2015.